Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price … Health Insurance Funds. The analysis was conducted for all oncology pharmaceuticals that underwent the early benefit …. Further analyses should be performed when more oncology pharmaceuticals have passed the early benefit assessment. …

. India ranks third in terms of volume of medicines produced, and is a major global supplier of generic medicines. However …, India depends heavily on the import of several raw materials used to produce some of these medicines. Main Body: This paper … dependence, especially regarding the secure access to essential medicines. India needs a conducive ecosystem to capitalize on the …